Does oral chemotherapy venetoclax combined with rituximab improve survival in patients with relapsed or refractory chronic lymphocytic leukemia?

Research output: Contribution to journalComment/debate

Original languageEnglish
JournalJournal of Clinical Outcomes Management
Volume25
Issue number6
StatePublished - Jun 2018

Cite this